YMC E-Journal Januar 2022

New App Note

UHPLC analysis of cyclic peptides using LC/MS compatible conditions

Get to know the significant advantages of YMC-Triart Bio C4! This new application note shows why this stationary phase is the ideal choice for the analysis of cyclic peptides.
These compounds are highly valuable drug candidates since their cyclic ring structure provides various advantages over their linear counterpart. This is the reason why they are increasingly becoming the focus in biopharmaceutical research.In this application note, you will discover the benefits of using an UHPLC YMC-Triart Bio C4 column for the analysis of the cyclic peptides polymyxin B sulfate, bacitracin, daptomycin and cyclosporin A. Best of all, the analysis is performed using LC/MS compatible conditions for improved selectivity and sensitivity!

For further information on YMC-Triart Bio columns, please see our download below.

Downloads

An overview of information that might be interesting for:

YMC-BioLC brochure
Application Note UHPLC analysis
Seminaranmeldung

Further Topics

Access to Care and Use Instructions & SDS

For the correct and safe handling of our products, we provide you with comprehensive instructions for care and use for each individual product, as well as informative safety data sheets. Discover important support documentations for the YMC products.

Read more

Access to useful online-configurators

Whether the scale-up calculator, flow rate calculator or column volume calculator – we offer you various helpful online configurators for selecting the right products. Get to know our digital configurators.

Read more

Catalogues and brochures

In the large YMC database you will find numerous downloads such as detailed publications, clear flyers and much more content. Discover our extensive download library.

Read more

Free customer service and individual newsletters

As a user of our Expertise Portal, you will receive free customer service and interesting information newsletters. You can decide for yourself on which topics you would like to receive information.

Read more